State AGs React to Mifepristone Ruling Limiting Mail-Order Access to Abortion Pill

The recent ruling from the U.S. Court of Appeals for the Fifth Circuit on the case of Alliance for Hippocratic Medicine v. Food & Drug Administration is engendering notable responses from various state attorneys general. The court’s decision, released on Wednesday, stipulates the cessation of mail-order access to the FDA-approved abortion pill, Mifepristone.

The judgement, partly vacating and partly affirming a district court order, was delivered by Circuit Judge Jennifer Walker Elrod. This resolution is being viewed as a pivotal moment in the continual debate over abortion rights and access to related medication. It has elicited reactions from state officials, such as Arizona Attorney General Kris Mayes. She stated her continued commitment to “protecting the rights of Arizonans to make their own private medical decisions without interference,” with an assurance that Arizona healthcare providers will keep their ability to prescribe Mifepristone for abortion and miscarriage care – a practice that was in place before these lawsuits commenced.

For more detailed coverage of the case and the impacts of this ruling, you can visit the original article here.